What is the share price of Hindustan Bio Sciences Ltd (HINDBIO) today?
The share price of HINDBIO as on 4th December 2025 is ₹5.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Hindustan Bio Sciences Ltd (HINDBIO) share?
The past returns of Hindustan Bio Sciences Ltd (HINDBIO) share are- Past 1 week: -4.76%
- Past 1 month: -19.68%
- Past 3 months: -28.84%
- Past 6 months: -41.54%
- Past 1 year: -46.23%
- Past 3 years: 33.49%
- Past 5 years: 79.25%
What are the peers or stocks similar to Hindustan Bio Sciences Ltd (HINDBIO)?
The peers or stocks similar to Hindustan Bio Sciences Ltd (HINDBIO) include:What is the market cap of Hindustan Bio Sciences Ltd (HINDBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hindustan Bio Sciences Ltd (HINDBIO) is ₹5.84 Cr as of 4th December 2025.What is the 52 week high and low of Hindustan Bio Sciences Ltd (HINDBIO) share?
The 52-week high of Hindustan Bio Sciences Ltd (HINDBIO) is ₹11.73 and the 52-week low is ₹5.70.What is the PE and PB ratio of Hindustan Bio Sciences Ltd (HINDBIO) stock?
The P/E (price-to-earnings) ratio of Hindustan Bio Sciences Ltd (HINDBIO) is 58.43. The P/B (price-to-book) ratio is 6.49.Which sector does Hindustan Bio Sciences Ltd (HINDBIO) belong to?
Hindustan Bio Sciences Ltd (HINDBIO) belongs to the Health Care sector & Biotechnology sub-sector.How to buy Hindustan Bio Sciences Ltd (HINDBIO) shares?
You can directly buy Hindustan Bio Sciences Ltd (HINDBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Hindustan Bio Sciences Ltd
HINDBIO Share Price
5.700.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HINDBIO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
HINDBIO Performance & Key Metrics
HINDBIO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 146.07 | 6.49 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
HINDBIO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
HINDBIO Company Profile
Hindustan Bio Sciences is engaged in biotechnology products business.
BIOCON
PE Ratio
51.17
51.17
1Y Return
2.28%
2.28%
Buy Reco %
70.59
70.59
ANTHEM
PE Ratio
82.39
82.39
1Y Return
9.36%
9.36%
Buy Reco %
66.67
66.67
ONESOURCE
PE Ratio
-1,063.50
-1,063.50
1Y Return
2.47%
2.47%
Buy Reco %
100.00
100.00
SAILIFE
PE Ratio
107.20
107.20
1Y Return
13.45%
13.45%
Buy Reco %
100.00
100.00
ACUTAAS
PE Ratio
88.16
88.16
1Y Return
51.31%
51.31%
Buy Reco %
100.00
100.00
HINDBIO Forecast
HINDBIO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
HINDBIO
HINDBIO
Income
Balance Sheet
Cash Flow
Annual Normal View
HINDBIO Income Statement
HINDBIO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.01 | 1.12 | 3.56 | 1.94 | 1.03 | 0.43 | 0.92 | 1.05 | 0.81 | 0.74 | ||||||||||
Raw Materials | 0.73 | 0.65 | 2.92 | 1.53 | 0.34 | 0.24 | 0.57 | 0.64 | 0.49 | 0.70 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.21 | 0.16 | 0.16 | 0.20 | 0.19 | 0.18 | 0.18 | 0.09 | 0.07 | |||||||||||
| Selling & Administrative Expenses | 0.33 | 0.29 | 0.36 | 0.22 | 0.25 | 0.22 | 0.20 | 0.16 | 0.12 | |||||||||||
| Operating & Other expenses | 0.21 | 2.28 | -0.02 | -0.15 | 1.18 | 0.30 | 0.00 | 0.10 | 0.03 | |||||||||||
EBITDA | -0.47 | -2.26 | 0.13 | 0.13 | -0.94 | -0.51 | -0.03 | 0.06 | 0.10 | 0.04 | ||||||||||
| Depreciation/Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | — | ||||||||||
| PBIT | -0.48 | -2.27 | 0.12 | 0.12 | -0.95 | -0.51 | -0.04 | 0.05 | 0.10 | 0.04 | ||||||||||
| Interest & Other Items | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | -0.49 | -2.27 | 0.11 | 0.11 | -0.96 | -0.51 | -0.04 | 0.05 | 0.10 | 0.04 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.04 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -0.49 | -2.27 | 0.11 | 0.07 | -0.94 | -0.51 | -0.04 | 0.05 | 0.10 | 0.04 | ||||||||||
| EPS | -0.48 | -2.21 | 0.11 | 0.07 | -0.92 | -0.50 | -0.07 | 0.08 | 0.10 | 0.04 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HINDBIO Company Updates
HINDBIO Stock Peers
HINDBIO Past Performance & Peer Comparison
HINDBIO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Hindustan Bio Sciences Ltd | 58.43 | 6.49 | — |
| Biocon Ltd | 51.17 | 1.87 | 0.12% |
| Anthem Biosciences Ltd | 82.39 | 15.43 | — |
| Onesource Specialty Pharma Ltd | -1,063.50 | 3.25 | — |
HINDBIO Stock Price Comparison
Compare HINDBIO with any stock or ETFCompare HINDBIO with any stock or ETF
HINDBIO
HINDBIO Holdings
HINDBIO Shareholdings
HINDBIO Promoter Holdings Trend
HINDBIO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HINDBIO Institutional Holdings Trend
HINDBIO Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 3.17%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
HINDBIO Shareholding Pattern
HINDBIO Shareholding Pattern
HINDBIO Shareholding History
HINDBIO Shareholding History
Foreign Institutions
smallcases containing HINDBIO stock
smallcases containing HINDBIO stock
Looks like this stock is not in any smallcase yet.
HINDBIO Events
HINDBIO Events
HINDBIO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HINDBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HINDBIO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HINDBIO has not given any dividends in last 5 years
HINDBIO Dividends
HINDBIO Dividends
Hmm, looks like data is unavailable here. Please come back after some timeHINDBIO Stock News & Opinions
HINDBIO Stock News & Opinions
Articles & Videos
Earnings
Hindustan Bio Sciences reports standalone net loss of Rs 0.06 crore in the September 2025 quarter
Net loss of Hindustan Bio Sciences reported to Rs 0.06 crore in the quarter ended September 2025 as against net profit of Rs 0.08 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 0.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales00.41 -100 OPM %017.07 - PBDT-0.060.08 PL PBT-0.060.08 PL NP-0.060.08 PL Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Hindustan Bio Sciences schedules board meeting
Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Hindustan Bio Sciences to convene AGM
Hindustan Bio Sciences announced that the 33th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Hindustan Bio Sciences standalone net profit declines 87.50% in the June 2025 quarter
Net profit of Hindustan Bio Sciences declined 87.50% to Rs 0.01 crore in the quarter ended June 2025 as against Rs 0.08 crore during the previous quarter ended June 2024. Sales declined 21.95% to Rs 0.32 crore in the quarter ended June 2025 as against Rs 0.41 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales0.320.41 -22 OPM %017.07 - PBDT0.010.08 -88 PBT0.010.08 -88 NP0.010.08 -88 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Hindustan Bio Sciences to announce Quarterly Result
Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 31 July 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Hindustan Bio Sciences standalone net profit rises 175.00% in the March 2025 quarter
Net profit of Hindustan Bio Sciences rose 175.00% to Rs 0.11 crore in the quarter ended March 2025 as against Rs 0.04 crore during the previous quarter ended March 2024. Sales declined 2.56% to Rs 0.38 crore in the quarter ended March 2025 as against Rs 0.39 crore during the previous quarter ended March 2024. For the full year,net profit rose 66.67% to Rs 0.10 crore in the year ended March 2025 as against Rs 0.06 crore during the previous year ended March 2024. Sales declined 21.36% to Rs 0.81 crore in the year ended March 2025 as against Rs 1.03 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.380.39 -3 0.811.03 -21 OPM %26.3210.26 -12.354.85 - PBDT0.110.04 175 0.100.07 43 PBT0.110.04 175 0.100.06 67 NP0.110.04 175 0.100.06 67 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Hindustan Bio Sciences to announce Quarterly Result
Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Hindustan Bio Sciences announces board meeting date
Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 23 April 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Hindustan Bio Sciences reports standalone net loss of Rs 0.04 crore in the December 2024 quarter
Net loss of Hindustan Bio Sciences reported to Rs 0.04 crore in the quarter ended December 2024 as against net profit of Rs 0.07 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 as against Rs 0.32 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales00.32 -100 OPM %018.75 - PBDT-0.040.07 PL PBT-0.040.07 PL NP-0.040.07 PL Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Hindustan Bio Sciences to conduct board meeting
Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 January 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -16.03%, vs industry avg of 21.23%
Over the last 5 years, market share decreased from 0.02% to 0%
Over the last 5 years, net income has grown at a yearly rate of 7.39%, vs industry avg of 23.38%